| Issuer | % of Class | Filed |
|---|---|---|
|
WF Holding Limited
13G
WFF · G9627R107
|
9.9% |
10/21/2026
Event 10/14/2026
|
|
DarkIris Inc.
13G/A
Amendment 1
DKI · G2657S103
|
4.9% |
10/20/2026
Event 10/16/2026
|
|
China SXT Pharmaceuticals, Inc.
13G
SXTC · G2161P157
|
9.9% |
10/15/2026
Event 10/8/2026
|
|
DarkIris Inc.
13G
DKI · G2657S103
|
11.7% |
10/15/2026
Event 10/8/2026
|
|
Neo-Concept International Group Holdings Limited
13G
NCI · G6421C138
|
9.9% |
10/7/2026
Event 9/30/2026
|
|
NFT Limited
13G/A
Amendment 1
MI · G6363T123
|
4.9% |
9/29/2026
Event 9/23/2026
|
|
Nuwellis, Inc.
13G/A
Amendment 1
NUWE · 67113Y801
|
4.9% |
9/18/2026
Event 9/17/2026
|
|
Singularity Future Technology Ltd.
13G/A
Amendment 1
SGLY · 82935V406
|
4.9% |
9/10/2026
Event 8/28/2026
|
|
Jupiter Neurosciences, Inc.
13G/A
Amendment 1
JUNS · 48208B302
|
3.3% |
8/28/2026
Event 8/21/2026
|
|
NFT Limited
13G
MI · G6363T123
|
9.9% |
8/28/2026
Event 8/21/2026
|
|
Elong Power Holding Limited
13G/A
Amendment 1
ELPW · G3016G111
|
4.9% |
8/28/2026
Event 8/14/2026
|
|
Jupiter Neurosciences, Inc.
13G
JUNS · 48208B302
|
8.4% |
8/28/2026
Event 8/21/2026
|
|
Singularity Future Technology Ltd.
13G
SGLY · 82935V406
|
9.5% |
8/25/2026
Event 8/18/2026
|
|
Nuwellis, Inc.
13G
NUWE · 67113Y801
|
7.0% |
8/7/2026
Event 7/31/2026
|
|
Elong Power Holding Limited
13G
ELPW · G3016G111
|
9.9% |
7/13/2026
Event 7/10/2026
|
|
AIM ImmunoTech Inc.
13G
AIM · 00901B303
|
9.9% |
5/12/2026
Event 5/7/2026
|
|
Healthcare Triangle, Inc.
13G/A
Amendment 1
HCTI · 42227W405
|
0.2% |
3/5/2026
Event 3/4/2026
|
|
Healthcare Triangle, Inc.
13G
HCTI · 42227W405
|
7.4% |
3/2/2026
Event 2/26/2026
|
|
Digital Currency X Technology Inc.
13G/A
Amendment 1
DCX · G4465R129
|
0.6% |
2/5/2026
Event 12/31/2025
|
|
AlphaTON Capital Corp
13G/A
Amendment 1
ALP · G7185A136
|
4.5% |
2/3/2026
Event 1/28/2026
|
|
Signing Day Sports, Inc.
13G/A
Amendment 1
SGN · 82670R305
|
0% |
1/22/2026
Event 1/20/2026
|
|
Signing Day Sports, Inc.
13G
SGN · 82670R305
|
9.9% |
1/16/2026
Event 1/13/2026
|
|
AlphaTON Capital Corp
13G
ALP · G7185A136
|
9.9% |
1/16/2026
Event 1/13/2026
|
|
Phio Pharmaceuticals Corp.
13G/A
Amendment 5
PHIO · 71880W501
|
4.9% |
12/11/2025
Event 12/8/2025
|
|
Chijet Motor Company, Inc.
13G
DCX · G4465R129
|
9.9% |
11/28/2025
Event 11/24/2025
|
|
Phio Pharmaceuticals Corp.
13G/A
Amendment 4
PHIO · 71880W501
|
6.5% |
11/24/2025
Event 11/20/2025
|
|
Phio Pharmaceuticals Corp.
13G/A
Amendment 3
PHIO · 71880W501
|
4.9% |
11/12/2025
Event 11/7/2025
|
|
Phio Pharmaceuticals Corp.
13G/A
Amendment 2
PHIO · 71880W501
|
9.8% |
11/6/2025
Event 11/3/2025
|
|
Co-Diagnostics, Inc.
13G/A
Amendment 3
CODX · 189763105
|
3.7% |
10/30/2025
Event 10/28/2025
|
|
Co-Diagnostics, Inc.
13G/A
Amendment 2
CODX · 189763105
|
9.9% |
10/30/2025
Event 10/28/2025
|
|
Co-Diagnostics, Inc.
13G/A
Amendment 1
CODX · 189763105
|
4.6% |
9/19/2025
Event 9/18/2025
|
|
Co-Diagnostics, Inc.
13G
CODX · 189763105
|
9.9% |
9/18/2025
Event 9/17/2025
|
|
Silexion Therapeutics Corp
13G/A
Amendment 1
SLXN · G1281K130
|
4.9% |
9/15/2025
Event 9/11/2025
|
|
Silexion Therapeutics Corp
13G
SLXN · G1281K130
|
6.2% |
9/15/2025
Event 9/11/2025
|
|
Purple Biotech Ltd.
13G/A
Amendment 1
PPBT · 74638P208
|
4.9% |
9/9/2025
Event 9/4/2025
|
|
Purple Biotech Ltd.
13G
PPBT · 74638P208
|
9.9% |
9/9/2025
Event 9/4/2025
|
|
Phio Pharmaceuticals Corp.
13G/A
Amendment 1
PHIO · 71880W501
|
4.9% |
8/7/2025
Event 8/4/2025
|
|
Rani Therapeutics Holdings, Inc.
13G/A
Amendment 1
RANI · 753018100
|
4.3% |
7/23/2025
Event 7/22/2025
|
|
60 Degrees Pharmaceuticals, Inc.
13G/A
Amendment 1
SXTP · 83006G401
|
4.9% |
7/17/2025
Event 7/15/2025
|
|
60 Degrees Pharmaceuticals, Inc.
13G
SXTP · 83006G401
|
9.9% |
7/17/2025
Event 7/15/2025
|
|
Rani Therapeutics Holdings, Inc.
13G
RANI · 753018100
|
9.9% |
7/17/2025
Event 7/14/2025
|
|
Venus Concept Inc.
13G/A
Amendment 3
VERO · 92332W303
|
4.9% |
6/11/2025
Event 6/6/2025
|
|
Venus Concept Inc.
13G/A
Amendment 2
VERO · 92332W303
|
5.9% |
6/11/2025
Event 6/6/2025
|
|
Pasithea Therapeutics Corp.
13G/A
Amendment 1
KTTA · 70261F202
|
4.9% |
5/9/2025
Event 5/7/2025
|
|
Pasithea Therapeutics Corp.
13G
KTTA · 70261F202
|
5.7% |
5/9/2025
Event 5/6/2025
|
|
Can-Fite BioPharma Ltd.
13G/A
Amendment 1
CANF · 13471N300
|
4.1% |
4/23/2025
Event 4/22/2025
|
|
Can-Fite BioPharma Ltd.
13G
CANF · 13471N300
|
9.7% |
4/16/2025
Event 4/14/2025
|
|
Venus Concept Inc.
13G/A
Amendment 1
VERO · 92332W303
|
0% |
4/14/2025
Event 4/11/2025
|
|
Venus Concept Inc.
13G
VERO · 92332W303
|
8.0% |
4/11/2025
Event 4/9/2025
|
|
Dogwood Therapeutics, Inc.
13G/A
Amendment 1
DWTX · 92829J203
|
3.7% |
3/17/2025
Event 3/14/2025
|
|
Dogwood Therapeutics, Inc.
13G
DWTX · 92829J203
|
6.1% |
3/17/2025
Event 3/12/2025
|
|
Lixte Biotechnology Holdings, Inc.
13G/A
Amendment 1
NMAD · 539319301
|
4.5% |
2/18/2025
Event 2/14/2025
|
|
Lixte Biotechnology Holdings, Inc.
13G
NMAD · 539319301
|
8.1% |
2/13/2025
Event 2/11/2025
|
|
Enveric Biosciences, Inc.
13G/A
Amendment 1
ENVB · 29405E208
|
4.9% |
2/4/2025
Event 1/31/2025
|
|
Enveric Biosciences, Inc.
13G
ENVB · 29405E208
|
8.7% |
2/4/2025
Event 1/30/2025
|
|
SuperCom Ltd.
13G/A
Amendment 1
SPCB · M87095309
|
3.6% |
2/4/2025
Event 1/31/2025
|
|
Singularity Future Technology Ltd.
13G/A
Amendment 1
SGLY · 82935V307
|
0% |
2/3/2025
Event 1/31/2025
|
|
SuperCom Ltd.
13G
SPCB · M87095309
|
7.8% |
1/31/2025
Event 1/30/2025
|
|
Singularity Future Technology Ltd.
13G
SGLY · 82935V307
|
5.6% |
1/28/2025
Event 1/24/2025
|
|
Phio Pharmaceuticals Corp.
13G
PHIO · 71880W501
|
9.9% |
1/23/2025
Event 12/19/2024
|
|
Blue Hat Interactive Entertainment Technology
13G/A
Amendment 1
BHAT · G1329V205
|
0% |
1/21/2025
Event 1/13/2025
|
|
Blue Hat Interactive Entertainment Technology
13G
BHAT · G1329V205
|
8.1% |
1/16/2025
Event 1/5/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.